CSIMarket
 
Yew Bio pharm Group Inc   (YEWB)
 

Yew Bio Pharm Group Inc's Customers Performance

YEWB



 
YEWB's Source of Revenues During the corresponding time, Yew Bio Pharm Group Inc saw a revenue deteriorated by -98.94 % year on year, sequentially revenue fell by -99.26 %. While revenue at the Yew Bio Pharm Group Inc 's corporate clients

List of YEWB Customers




for the same period Yew Bio Pharm Group Inc revnue deteriorated by -98.94 % year on year, sequentially revenue fell by -99.26 %.

List of YEWB Customers

Yew Bio Pharm Group Inc's Business Units






Yew Bio Pharm Group Inc's Comment on Sales, Marketing and Customers



We sell most of our products in the Chinese domestic market. The sale of yew trees for reforestation in Heilongjiang Province and Jilin Province is to both state-owned enterprises and private businesses.

We sold our products to a relatively small number of customers. For the year ended December 31, 2015, the following customers accounted for 10% or more of our consolidated revenue:

Yew Pharmaceutical accounted for approximately 57% of our consolidated revenue

Dafurong Biotechnology (HK) Ltd., accounted for approximately 36% of our consolidated revenue

For the year ended December 31, 2014, the following customers accounted for 10% or more of our consolidated revenue:

Yew Pharmaceutical accounted for approximately 27% of our consolidated revenue

Shenzhen Dongfang Shangcheng Trading Co., Ltd., accounted for approximately 16% of our consolidated revenue

Yew Pharmaceutical is the manufacturer of Zi Shan and other pharmaceutical products, and is owned, directly and indirectly, primarily by Zhiguo Wang and Guifang Qi.

The sale of furniture and handicrafts from our cultivated yew trees, as well as the sale of potted yew trees for display in homes and offices, is to the Chinese domestic market. We exhibit and warehouse potted yew trees, handicrafts and furniture at a facility located in Harbin.

Retail prices for potted yew trees are high by Chinese standards, but have remained stable. We provide the potted yew trees that we sell, from our nurseries. The supply of ceramic pots that we purchase from third-parties suppliers that we use to transplant cultivated yew trees is good and prices are stable.

The sale of handicrafts is not seasonal. In December 2012, we closed our store in Harbin. Until December 2014, our headquarter warehouse in Harbin maintained inventory of a range of handicrafts and furniture, for sale and can also take orders for products custom-made to the specifications of our customers. We currently use this facility to exhibit and warehouse our products. Prices and delivery time for custom pieces vary depending upon the item and time of year, since our artisans work primarily during the warmer months from April to September.

Zi Shan is marketed and sold exclusively through Yew Pharmaceutical, under the Development Agreement. Yew Pharmaceutical is also our major purchaser of yew raw material used in the production of TCM. Yew Pharmaceutical is owned directly and indirectly primarily by Mr. Wang and Madame Qi.

Other TCM that is produced by manufacturers who buy yew raw material from us is marketed and sold by them to third party users, including hospitals.





Yew Bio Pharm Group Inc’s Comment on Sales, Marketing and Customers


We sell most of our products in the Chinese domestic market. The sale of yew trees for reforestation in Heilongjiang Province and Jilin Province is to both state-owned enterprises and private businesses.

We sold our products to a relatively small number of customers. For the year ended December 31, 2015, the following customers accounted for 10% or more of our consolidated revenue:

Yew Pharmaceutical accounted for approximately 57% of our consolidated revenue

Dafurong Biotechnology (HK) Ltd., accounted for approximately 36% of our consolidated revenue

For the year ended December 31, 2014, the following customers accounted for 10% or more of our consolidated revenue:

Yew Pharmaceutical accounted for approximately 27% of our consolidated revenue

Shenzhen Dongfang Shangcheng Trading Co., Ltd., accounted for approximately 16% of our consolidated revenue

Yew Pharmaceutical is the manufacturer of Zi Shan and other pharmaceutical products, and is owned, directly and indirectly, primarily by Zhiguo Wang and Guifang Qi.

The sale of furniture and handicrafts from our cultivated yew trees, as well as the sale of potted yew trees for display in homes and offices, is to the Chinese domestic market. We exhibit and warehouse potted yew trees, handicrafts and furniture at a facility located in Harbin.

Retail prices for potted yew trees are high by Chinese standards, but have remained stable. We provide the potted yew trees that we sell, from our nurseries. The supply of ceramic pots that we purchase from third-parties suppliers that we use to transplant cultivated yew trees is good and prices are stable.

The sale of handicrafts is not seasonal. In December 2012, we closed our store in Harbin. Until December 2014, our headquarter warehouse in Harbin maintained inventory of a range of handicrafts and furniture, for sale and can also take orders for products custom-made to the specifications of our customers. We currently use this facility to exhibit and warehouse our products. Prices and delivery time for custom pieces vary depending upon the item and time of year, since our artisans work primarily during the warmer months from April to September.

Zi Shan is marketed and sold exclusively through Yew Pharmaceutical, under the Development Agreement. Yew Pharmaceutical is also our major purchaser of yew raw material used in the production of TCM. Yew Pharmaceutical is owned directly and indirectly primarily by Mr. Wang and Madame Qi.

Other TCM that is produced by manufacturers who buy yew raw material from us is marketed and sold by them to third party users, including hospitals.








YEWB's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Yew Bio pharm Group Inc 2.04 29.05 0.39 86
SUBTOTAL 0.00 0.00 0.00 -

Sources: Yew Bio pharm Group Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Yew Bio pharm Group Inc’s corporate clients.
For your research, we’ve provided 9 tables on Yew Bio pharm Group Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.